BIOT-YG-I FIA Analyzer (Fluorescence Immunoassay Analyzer)

BIOT-YG-I is a fluorescence immunoassay system with single channel that measures the quantitative concentration of a targeted analyte in human blood and urine.

FLI-100 FIA Analyzer

The ALL NEW FLI-100 Analyser represents an elevated standard at Biotime, in pursuing simplicity, quality assurance, and data security for healthcare organizations. Designed for quantitative in vitro assay determinations, the Biotime FLI-100 analyser was purposefully built to support immunoassay analysis for a broad range of applications – from biomarker work to infectious disease testing. The analyser’s immunofluorescence technology yields high sensitivity, reliable, and reproducible results for convenient point-of-care diagnostic testing on one device with a small footprint.

ICE-100E Incubation Chamber

The incubation chamber is an auxiliary device for Biotime’s fluorescence immunoassay analyzer. The reaction temperature and time is critical for test results. The incubation chamber provides an optimized environment as well as automatic timers for test reactions to improve the reliability of test results.

FLI-600 FIA Analyzer

FLI-600 is a fluorescent immunoassay system with 6 channels that uses blood and urine to measure the quantitative concentration of targeted analyte. Its automated test process enables to carry out multiple simultaneous tests for six different samples.

FLI-600 FIA Immunoassay Analyzer

ICE-100E Incubation Chamber

BNP Rapid Quantitative Test

During heart failure, the heart makes two proteins, called B-type natriuretic peptide (BNP) and N-terminal-pro-BNP (NT-proBNP). Levels of both in the blood go up when heart failure gets worse and go down when it gets better.

COVID-19 Ag & Flu A/B Combo Self Test

COVID-19 Ag & Flu A/B Combo Self Test is a colloidal gold immunochromatography intended for the in vitro rapid, simultaneous qualitative detection and differentiation of N protein from SARS-CoV-2, influenza A and influenza B directly from nasal swab specimens obtained from individuals, who are suspected of COVID-19, influenza A or influenza B infection. Results are for the simultaneous identification of N protein of SARS-CoV-2, influenza A and influenza B.

RSV Antigen Rapid Test

The RSV antigen rapid test is intended to be used by professionals as a screening test and to provide preliminary test results to help diagnose acute RSV virus infection. It provides only an initial screening test result. For professional in vitro diagnostic use only.

Model	BIOT-YG-I
Principle	Fluorescent immunochromatography
Specimen	Whole Blood/ Serum/ Plasma/ Urine
Power adapter	AC220V, 3A, 50/60Hz
Interface	RS232, USB, Ethernet (Direct connection to LIS / HIS)
Information input	Touch screen, barcode reader
Data Storage	5,000 test records automatically storage
Incubation temperature	25℃±1℃
Size	225×220×113mm
Weight	2.5kg

Cardiac Markers	CTnI, MYO, CK-MB, NT-proBNP, D-Dimer, CTnI/MYO/CK-MB, CTnI/MYO/CK-MB/NT-proBNP/D-Dimer, HCY, h-FABP, BNP, ST2, LP-PLA2
Hormones Markers	β-HCG, PROG, E2, TES, FSH, LH, PRL, FSH/LH/PRL, AMH
Inflammation Markers	PCT, SAA, hsCRP+CRP, CRP/SAA, Total IgE, IL-6
Thyroid Markers	TSH, TT3, TT4, fT3, fT4
Diabetes and Renal Injury	HbA1c, MAU, Cys-C, NGAL
Tumor Markers	CEA, AFP, CEA/AFP, tPSA, fPSA, PGI, PGII, PGI/PGII
Health Check	25(OH)-D, Ferritin
Infectious Disease	HBsAg, HCV